Synthesis, structural characterization and cytotoxic activity of organotin derivatives of indomethacin

被引：21

作者：

Camacho-Camacho, Carlos ^{[1
]}

Rojas-Oviedo, Irma ^{[1
]}

Paz-Sandoval, M. Angeles ^{[2
]}

Cardenas, Jorge ^{[3
]}

Toscano, Alfredo ^{[3
]}

Gielen, Marcel ^{[4
]}

Sosa, Lidia Barron ^{[5
]}

Bartez, Francisco Sanchez ^{[5
]}

Gracia-Mora, Isabel ^{[5
]}

机构：

[1] Univ Autonoma Metropolitana Iztapalapa, Dept Sistemas Biol, Mexico City 04960, DF, Mexico

[2] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Quim, Mexico City 07000, DF, Mexico

[3] Univ Nacl Autonoma Mexico, Inst Quim, Mexico City 04510, DF, Mexico

[4] Free Univ Brussels, HNMR Unit, Fac Sci Appl, B-1050 Brussels, Belgium

[5] Univ Circuito Exteriors, Fac Quim Edificio E Cd, Mexico City 04510, DF, Mexico

来源：

APPLIED ORGANOMETALLIC CHEMISTRY | 2008年 / 22卷 / 03期

关键词：

organotin; carboxylates; indomethacin; cytotoxic;

D O I：

10.1002/aoc.1366

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

The synthesis, characterization and cytotoxic properties in vitro of tri-n-butyltin 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate (1), tri-phenyltin 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate (2), tetra-n-butyltin[bis1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetato]distannoxane (3) and di-n-butyltin bis-1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate (4) are described. These compounds have been characterized by H-1, C-13 and Sn-119 NMR spectroscopy in solution and Sn-119 NMR in the solid state, infrared spectroscopy, elemental analysis and X-ray diffraction for compound 1. The growth inhibition effects of compounds 1-4 against the lung adenocarcinoma cell line SK-LU-1 as well as the cervical cancer cell line HeLa were determined. Compounds 1 and 2 exhibit cytotoxic activity, whereas compounds 3 and 4 are inactive. Copyright (c) 2008 John Wiley & Sons, Ltd.

引用

页码：171 / 176

页数：6

共 35 条

[1]

ALLEY MC, 1988, CANCER RES, V48, P589

[2] Substituted E-3-(2-chloro-3-indolylmethylene)1, 3-dihydroindol-2-ones with antitumor activity [J].

Andreani, A ;

Granaiola, M ;

Leoni, A ;

Locatelli, A ;

Morigi, R ;

Rambaldi, M ;

Garaliene, V ;

Farruggia, G ;

Masotti, L .

BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (05) :1121-1128

[3]

BOUALAM M, 1991, MAIN GROUP MET CHEM, V14, P41

[4]

Camacho CC, 2000, MAIN GROUP MET CHEM, V23, P433

[5]

Crowe A.J., 1988, MET-BASED DRUGS, V1, P103

[6] Chiral self-assembly of methyltin(IV)-naproxenates:: Combining dative Sn-O bonds, secondary Sn•••O interactions and C-H•••O hydrogen bonding to make an inter-helical meander-shaped network and a cross-linked Z-shaped ribbon [J].

Deák, A ;

Tárkányi, G .

JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2006, 691 (08) :1693-1702

[7] Organotin adducts of indomethacin: synthesis, crystal structures and spectral characterization of the first organotin complexes of indomethacin [J].

Galani, A ;

Kovala-Demertzi, D ;

Kourkoumelis, N ;

Koutsodimou, A ;

Dokorou, V ;

Ciunik, Z ;

Russo, U ;

Demertzis, MA .

POLYHEDRON, 2004, 23 (11) :2021-2030

[8] Tin-based antitumour drugs [J].

Gielen, M .

COORDINATION CHEMISTRY REVIEWS, 1996, 151 :41-51

[9] CRYSTAL-STRUCTURE AND IN-VITRO ANTITUMOR-ACTIVITY OF DIBUTYLBIS(5-CHLORO-2-HYDROXYBENZOATO)TIN(IV) [J].

GIELEN, M ;

BOUALAM, M ;

MAHIEU, B ;

TIEKINK, ERT .

APPLIED ORGANOMETALLIC CHEMISTRY, 1994, 8 (01) :19-23

[10]

Gielen M, 2001, MAIN GROUP MET CHEM, V24, P873

← 1 2 3 4 →